Please sign in to follow a disease.
Zapping the brain to calm anxiety: new trial tests tACS with mindfulness
NCT ID NCT07648797
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a gentle brain stimulation technique called tACS can make mindfulness therapy work better for people with generalized anxiety disorder. 99 adults will receive either real or fake tACS while doing mindfulness exercises. Researchers will track anxiety symptoms, worry, and brain activity to see if the combination helps more than therapy alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial alternating current stimulation (tACS) device
- What this could lead to
- If it works, this could offer a new way to boost mindfulness therapy for anxiety, potentially reducing symptoms more effectively than therapy alone.
- What could go wrong
- This is an early-stage trial with no phase, so results are uncertain. The device is experimental, and benefits may be small or not last long.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 99 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Outpatients or inpatients of The Second Xiangya Hospital of Central South University. * Diagnosis of generalized anxiety disorder as the primary diagnosis according to the International Classification of Diseases 11th Revision (ICD-11) diagnostic criteria, confirmed by two experienced psychiatrists. * Hamilton Anxiety Rating Scale (HAMA) total score of 14 or higher. * Aged 18 to 60 years, inclusive. * Right-handed. * Junior high school education or above, with sufficient ability to understand the study procedures, complete informed consent, clinical scales, and cognitive assessments. * Currently not using anxiolytic or antidepressant medications, or receiving a stable medication regimen for at least 1 month before enrollment, with no planned changes in the medication regimen during the 2-week treatment period unless clinically necessary. * Voluntarily agrees to participate in the study, signs the informed consent form, and is able to comply with study visits, treatment procedures, laboratory examinations, and other study requirements. Exclusion Criteria: * Presence of psychotic symptoms. * Meeting ICD-11 diagnostic criteria for schizophrenia or other primary psychotic disorders, bipolar or related disorders, current depressive episode, dysthymic disorder, or post-traumatic stress disorder currently or within the past year. * Organic brain disease or severe physical illness, including but not limited to thyroid disease, systemic lupus erythematosus, diabetes, severe pulmonary, hepatic, or renal impairment, infection, or major trauma. * Clinically significant uncorrectable sensory impairment, such as hearing impairment that prevents effective communication. * Pregnancy or lactation. * Contraindications to transcranial electrical stimulation or related procedures, including metal implants in the body, intracranial hypertension, skull defects, brain tumor, severe heart disease, unstable vital signs due to serious physical illness, acute cerebrovascular disease, or a history of adverse reactions to electrical stimulation. * Any other condition that, in the investigator's judgment, makes the participant unsuitable for this study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Generalized anxiety disorder (GAD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Magnetic brain zaps may quiet anxiety: device trial puts it to the test
- Can the right electric pulse calm chronic worry?
- A brief therapy that builds on strengths may calm young adult anxiety
- Can brain and blood data predict Anxiety's future?
- Can a daily microdose of psilocybin calm chronic anxiety?
- Can online therapy or parent coaching ease childhood anxiety? a head-to-head trial aims to find out.